STILLWATER, Okla., February 12, 2007 —Pardalis, Inc. announced today that a certified copy of the Letters Patent issued by the Commonwealth of New Zealand has been received by the Company for its Common Point Authoring™ system. The Letters Patent were signed and sealed on December 8, 2005 by the New Zealand Commissioner of Patents but the documentation was not received by the Company until now.
“New Zealand has one of the world’s fastest growing biotechnology sectors,” said Pardalis CEO Steve Holcombe. “New Zealand’s biotechnology strength derives from more than 150 years of experience in genetically improving animals and plants, and creating one of the world’s most efficient agricultural economies. The knowledge gained as a world leader in agricultural primary production combines very well with a tradition of scientific research excellence.”
The New Zealand Letters Patent cover the same claims as previously issued to Pardalis, Inc. by the United States Patent and Trademark Office (USPTO) for patent #6,671,696, the parent patent for the Common Point Authoring™ system.
“The Letters Patent strictly commands all subjects whomsoever within New Zealand and its dependencies that they do not at any time either directly or indirectly make use or put into practice the Common Point Authoring™ invention without the consent, license, or agreement of Pardalis, Inc.,” said Holcombe. “To obtain similar protections in other countries outside of the United States, filings relevant to Pardalis’ USPTO issued patents are also being pursued under the Patent Cooperation Treaty in Australia, Brazil, Canada, China, Europe, Hong Kong, India, Japan, and Mexico.”
About Pardalis, Inc.
Pardalis' mission is to promote the sharing of confidential, trustworthy and traceable data along complex and poorly coordinated supply chains with innovative Common Point Authoring™ methods for protecting the ownership rights of information producers. For more information, call 877-OWN-DATA or visit http://www.pardalis.com.